FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Udit Verma

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Phenomena

Physiology

Transfection

Anatomy

Procedures

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Youn-Tae Kwak; Sofyan M Radaideh; Lianghao Ding; Rui Li; Eugene Frenkel; Michael D Story; Luc Girard; John Minna; Udit N Verma
Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressor.
Weiming Ouyang; Dongyun Zhang; Jingxia Li; Udit N Verma; Max Costa; Chuanshu Huang
Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.
Carlos R Becerra; Udit N Verma; Hia T Tran; Denise Tavana; Noelle S Williams; Eugene P Frenkel
Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Udit Verma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Youn-Tae Kwak; Sofyan M Radaideh; Lianghao Ding; Rui Li; Eugene Frenkel; Michael D Story; Luc Girard; John Minna; Udit N Verma
Cells lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic phenotype: role of IKKα as a tumor suppressor.
Molecular cancer research : MCR 2011;9(3):341-9.
2009: Weiming Ouyang; Dongyun Zhang; Jingxia Li; Udit N Verma; Max Costa; Chuanshu Huang
Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.
Journal of cellular physiology 2009;218(1):205-14.
2008: Carlos R Becerra; Udit N Verma; Hia T Tran; Denise Tavana; Noelle S Williams; Eugene P Frenkel
Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies.
American journal of clinical oncology 2008;31(3):219-25.
2006: Jun Guo; An-wu Zhou; Yu-cai Fu; Udit N Verma; Debu Tripathy; Eugene P Frenkel; Carlos R Becerra
Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil.
Acta pharmacologica Sinica 2006;27(10):1375-81.
2005: Youn-Tae Kwak; Rui Li; Carlos R Becerra; Debu Tripathy; Eugene P Frenkel; Udit N Verma
IkappaB kinase alpha regulates subcellular distribution and turnover of cyclin D1 by phosphorylation.
The Journal of biological chemistry 2005;280(40):33945-52.
2004: Jun Guo; Udit N Verma; Richard B Gaynor; Eugene P Frenkel; Carlos R Becerra
Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3333-41.
2004: Udit N Verma; Yumi Yamamoto; Shashi Prajapati; Richard B Gaynor
Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression.
The Journal of biological chemistry 2004;279(5):3509-15.
2004: Shashi Prajapati; Udit N Verma; Yumi Yamamoto; Youn-Tae Kwak; Richard B Gaynor
Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity.
The Journal of biological chemistry 2004;279(3):1739-46.
2003: Yumi Yamamoto; Udit N Verma; Shashi Prajapati; Youn-Tae Kwak; Richard B Gaynor
Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression.
Nature 2003;423(6940):655-9.
2003: Udit N Verma; Rama M Surabhi; Aurelia Schmaltieg; Carlos R Becerra; Richard B Gaynor
Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1291-300.
2003: Noelle Sevilir Williams; Richard B Gaynor; Shane Scoggin; Udit N Verma; Tunc Gokaslan; Clifford Simmang; Jason Fleming; Denise Tavana; Eugene P Frenkel; Carlos R Becerra
Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):931-46.
2003: Chris Albanese; Kongming Wu; Mark D'Amico; Christy Jarrett; David Joyce; Julian Hughes; James Hulit; Toshiyuki Sakamaki; Maofu Fu; Avri Ben-Ze'ev; Jacqueline F Bromberg; Carmela Lamberti; Udit N Verma; Richard B Gaynor; Stephen W Byers; Richard G Pestell
IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.
Molecular biology of the cell 2003;14(2):585-99.
2002: Kevin S Berman; Udit N Verma; Gwyndolen C Harburg; John D Minna; Melanie H Cobb; Richard B Gaynor
Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):354-60.
2001: C Lamberti; Keng-Mean Lin; Yumi Yamamoto; Udit N Verma; Inder M Verma; Stephen W Byers; Richard B Gaynor
Regulation of beta-catenin function by the IkappaB kinases.
The Journal of biological chemistry 2001;276(45):42276-86.
2001: Yumi Yamamoto; D W Kim; Youn-Tae Kwak; Shashi Prajapati; Udit N Verma; Richard B Gaynor
IKKgamma /NEMO facilitates the recruitment of the IkappaB proteins into the IkappaB kinase complex.
The Journal of biological chemistry 2001;276(39):36327-36.